Chairperson(s) : Thierry BRUE, Gérald RAVEROT, Philippe CHANSON, Nabila REKIB-MEJDOUB
Que faire au-delà du témozolomide en cas de tumeur hypophysaire agressive ?
Gérald RAVEROT, Lyon, FRANCETable ronde : trois défis cliniques en pathologie hypophysaire
Chairperson(s) : Philippe CHANSON, Nabila REKIB-MEJDOUBAdénome thyréotrope géant : quand la collaboration endocrinologie-Neurochirurgie fait la différence
Fatma MNIF, Sfax, TUNISIAChairperson(s) : Harriet SCHELLEKENS, Uberto PAGOTTO
Non-obesity effects of GLP-1 agonists (smoking and alcohol abuse)
Mette Kruse KLAUSEN, DENMARKChairperson(s) : Davide CARVALHO, Krystallenia ALEXANDRAKI
Neuroendocrinology of Reproduction Study Group -Case studies presentation
Paraskevi XEKOUKI, GREECEENEA European Postgraduate Course Neuroendocrinology of Reproduction
Josanne VASSALLO, MALTAAggressive Pituitary Tumors and Pituitary Carcinomas Study Group
Mirela-Diana ILIE, FRANCEChairperson(s) : Marta KORBONITS
Olfactory food signals in the regulation of satiety and whole body metabolism
Sophie STECULORUM, GERMANYChairperson(s) : Jérôme BERTHERAT, Sakina MHAOUTY-KODJA
Microbioma of the mother and development of hypothalamic circuits controlling appetite in the fetus
Sébastien BOURET, FRANCEChairperson(s) : Riccarda GRANATA, Clara ALVAREZ
Sympathetic Perineurial Cells: A New Interface for Energy Balance
Gitalee SARKER, UNITED KINGDOMChairperson(s) : Sabrina CHILOIRO, Cihan ATILA
Effects of a novel set of somatostatin/cortistatin analogues on pituitary neuroendocrine tumors
Federica MANGILI, Milan, ITALYMYC inhibition emerges as a potential therapy for fgSRL resistant patients in acromegaly
Paula DE PEDRO-CAMPOS, Badalona, SPAINChairperson(s) : Mirela Diana ILIE, Giampaolo TRIVELIN
Transcriptomics of pituitary tumors: molecular classification and clinical implications
Fabio BIOLETTO, ITALYAdvancing Pituitary Tumor Classifications Through Epigenomic Insights
Matthias DOTTERMUSCH, GERMANYChairperson(s) : Justo CASTANO, Krystallenia ALEXANDRAKI
Defining the Cellular Landscape of Multifocal Small Intestine Neuroendocrine Tumors
Netta MÄKINEN, UNITED STATESCurrent advances in the treatment of NETs: from targeted therapies to theranostic successes
Simona GLASBERG, ISRAELWill steroidomics and AI replace dynamic testing in endocrine tumor diagnosis?
Georgiana CONSTANTINESCU, GERMANYChairperson(s) : Peter WOLF, Nicoleta OLARESCU
A targeted proteomic approach reveals plasma biomarkers of active acromegaly
Nicoleta Cristina OLARESCU, Oslo, NORWAYProteomic Analysis of GH-secreting and Non Functioning Pituitary Adenomas
Francesco FERRAÙ, Messina, ITALY, Giordana SIRACUSANO, Messina, ITALYLifelong congenital untreated isolated GH deficiency does not alter human telomere length
Júnia R.O.L. SCHWEIZER, Munich, GERMANYChairperson(s) : Antoine TABARIN, Marily THEODOROPOULOU
Chairperson(s) : Dominique MAITER, Marta ARAUJO CASTRO
Specificities in the management of prolactinoma in children and adolescents
Joanne BLAIR, UNITED KINGDOMChairperson(s) : Pina KARDIOGLU, Frédéric CASTINETTI
Medical treatment of Cushing's syndrome: New concepts, new drugs
Rosario PIVONELLO, ITALY